Quintiles Transnational Holdings Aktie [WKN DE: A1T788 / ISIN: US74876Y1010]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Quintiles Transnational Holdings INC

11.05.23		IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award (Businesswire)
02.05.23		Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute (Businesswire)
27.04.23		IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance (Businesswire)
20.04.23		IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023 (Businesswire)
06.04.23		IQVIA to Announce First-Quarter 2023 Results on April 27, 2023 (Businesswire)
14.03.23		Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute (Businesswire)
01.03.23		IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023 (Businesswire)
23.02.23		IQVIA Publishes its 2022 Environmental, Social and Governance Report (Businesswire)
10.02.23		IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance (Businesswire)
09.02.23		IQVIA Named to FORTUNE’s 2023 List of "World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year (Businesswire)
31.01.23		IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China (Businesswire)
25.01.23		IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 (Businesswire)
18.01.23		Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute (Businesswire)
10.11.22		IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel (Businesswire)
26.10.22		IQVIA Reports Third-Quarter 2022 Results (Businesswire)
24.10.22		IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022 (Businesswire)
06.10.22		Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso (Businesswire)
03.10.22		IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022 (Businesswire)
28.09.22		IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation (Businesswire)
07.09.22		New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials (Businesswire)
02.09.22		IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022 (Businesswire)
15.08.22		IQVIA Wins Snowflake’s "Marketplace Healthcare and Life Sciences Partner of the Year” Award (Businesswire)
21.07.22		IQVIA Reports Second-Quarter 2022 Results (Businesswire)
07.07.22		IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022 (Businesswire)
06.07.22		IQVIA Recognized as a Leader in Life Science Sales and Marketing IT Outsourcing Services (Businesswire)
07.06.22		IQVIA Appoints Dr. Christina Mack Chief Scientific Officer of Real World Solutions (Businesswire)
01.06.22		Global Oncology R&D Surges While Cancer Care Disruptions Ease, Says IQVIA Institute for Human Data Science (Businesswire)
25.05.22		IQVIA CFO Ron Bruehlman to Speak at Jefferies Healthcare Conference on June 10, 2022 (Businesswire)
27.04.22		IQVIA Reports First-Quarter 2022 Results (Businesswire)
21.04.22		Spending on U.S. Medicines Rose 12% in 2021 Due to COVID-19 Vaccines and Therapies, Says IQVIA Institute for Human Data Science (Businesswire)
12.04.22		IQVIA to Announce First-Quarter 2022 Results on April 27, 2022 (Businesswire)
31.03.22		IQVIA Selected to Support EMA’s DARWIN EU® Coordination Centre Initiative (Businesswire)
15.03.22		IQVIA Launches OCE+ To Deliver Enhanced AI-Driven Customer Engagement (Businesswire)
14.03.22		IQVIA Appoints Costa Panagos President of Research & Development Solutions (R&DS) (Businesswire)
01.03.22		IQVIA selected to accelerate clinical development of VYVGART™ (efgartigimod alfa fcab) by argenx SE (Businesswire)
24.02.22		IQVIA Named Top CRO in 2021 WCG CenterWatch Independent Survey (Businesswire)
22.02.22		IQVIA Releases 2021 Environmental, Social, and Governance (ESG) Report (Businesswire)
10.02.22		IQVIA CFO Ron Bruehlman to Speak at Citi’s 2022 Virtual Healthcare Conference on February 24, 2022 (Businesswire)
10.02.22		Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for Human Data Science Report (Businesswire)
02.02.22		IQVIA Named to FORTUNE’s 2022 List of "World’s Most Admired Companies,” Ranked #1 in Health Care: Pharmacy and Other Services (Businesswire)
01.02.22		IQVIA to Announce Fourth-Quarter and Full-Year 2021 Results on February 15, 2022 (Businesswire)
26.01.22		Sheila A. Stamps Joins IQVIA Board of Directors (Businesswire)
24.01.22		Leslie Wims Morris Joins IQVIA Board of Directors (Businesswire)
24.06.21		IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials (Businesswire)
14.06.21		Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK (Businesswire)
20.05.21		IQVIA CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conference on June 2, 2021 (Businesswire)
19.05.21		Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science (Businesswire)
10.05.21		U.S. District Court Issues Favorable Decision for IQVIA Against Veeva (Businesswire)
03.05.21		IQVIA’s Orchestrated Customer Engagement (OCE) Solution Chosen to Support the Commercial Launch of Novel ADHD Drug (Businesswire)
29.04.21		Global Medicine Spending to Reach $1.6 Trillion in 2025 Excluding Spending on COVID-19 Vaccines, According to IQVIA Institute for Human Data Science Study (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Pierer Mobility-Aktie schwach: Gehälter für Angestellte von insolventer KTM noch vor Weihnachten

UNIQA Insurance-Aktie im Plus: UNIQA plant zu expandieren und Dividenden zu erhöhen

Ethereum Kurs Prognose: ETH massiv unterbewertet! Fällt jetzt das ATH?

Bundesheer wirbt nach KTM-Insolvenz um Mitarbeiter - Pierer Mobility-Aktie im Plus

EZB wird wohl Leitzinsen senken - wie stark?

OMV-Aktie verliert: OMV kündigt Liefervertrag mit Gazprom

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	15.12.2024 06:38
Kaufwert:	EUR
	Hinzufügen Speichern